Stay updated on Pembrolizumab in Multiple Myeloma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in Multiple Myeloma Clinical Trial page.

Latest updates to the Pembrolizumab in Multiple Myeloma Clinical Trial page
- Check7 days agoChange DetectedAdded 'Multiple myeloma' as a topic and included a related topic link to MedlinePlus Genetics.SummaryDifference0.2%

- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedAdded Revision: v3.5.0; removed related topics 'Multiple myeloma' and 'MedlinePlus Genetics' and the reference 'Revision: v3.4.3'.SummaryDifference0.2%

- Check29 days agoChange DetectedAdded related topics for Multiple myeloma and MedlinePlus Genetics on the study page to improve navigation and context.SummaryDifference0.2%

- Check36 days agoChange DetectedAdded Revision: v3.4.3; removed the terms 'Multiple myeloma' and related topics (MedlinePlus Genetics) and the older Revision: v3.4.2.SummaryDifference0.2%

- Check57 days agoChange DetectedThe page lists revision v3.4.2, replacing v3.4.1, indicating a minor metadata update with no changes to trial data or core content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check64 days agoChange DetectedRevision: v3.4.1 replaces v3.4.0 on the page, a minor version update with no changes to study data or navigation. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab in Multiple Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Multiple Myeloma Clinical Trial page.